The top five tweets: From Brexit to Huntington’s disease — what did EPM readers enjoy this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. Making it onto our list in fifth place is the news of the FDA’s approval of Sanofi’s short-acting insulin as a ‘follow on’ treatment for diabetes.

4. The research announcement revealing that a drug lowers the amount of harmful Huntington’s disease proteins in humans makes it in at number four.

3. This week’s middle position goes to the research released by BIA and ABPI on the impact of Brexit on healthcare.

2. Just missing out on the top spot is the news from Autolus about its data for pan-checkout blocking tech that can restore the function of CAR T-cells.

1. Industry reactions to the Brexit progression announcement is this week’s number one.